COMPASS Pathways plc (CMPS:NASDAQ) closed at $11.18 on October 23, 2026, down 3.87% on the day. The stock trades 29.6% below its 52-week high of $15.87 and 129.1% above its 52-week low of $4.88. Over the past year, it gained 78.0%. COMPASS Pathways plc is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, CMPS closed higher on 116 days (46%). Its best day was April 20, 2026 (+42.04%) and its worst was November 5, 2025 (-17.19%). The stock moved 10% or more in a single session 11 times. It opened at least 5% above the previous day's high 4 times.
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
Find more stocks like CMPS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.